BioCentury
ARTICLE | Clinical News

Mentax data

September 23, 1996 7:00 AM UTC

DERM presented data from a vehicle-controlled Phase III trial that showed rapid and high cure rates of ringworm in the 78 patients evaluated in the 91-patient trial. As reported at the Interscience Conference on Antimicrobial Agents and Chemotherapy, once-daily application of the 1 percent butenafine cream for two weeks gave an 88 percent rate of fungus eradication, and an 81 percent rate of complete healing of the lesion. Relief was experienced within seven days, and patients continued to improve at least four weeks after use was discontinued. ...